Cite
Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial
MLA
Tetsuya Tobaru, et al. “Impact of Lesion Calcification on Angiographic Outcomes after Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold Implantation: An Observation from the ABSORB Japan Trial.” EuroIntervention, vol. 12, no. 14, Jan. 2017, pp. 1738–46. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ab69e4a41d28bc58fba51d25e9549029&authtype=sso&custid=ns315887.
APA
Tetsuya Tobaru, Kengo Tanabe, Tomohiro Kawasaki, Gregg W. Stone, Patrick W. Serruys, Koichi Kishi, Yoshihiro Morino, Shih-Wa Ying, Hajime Kusano, Yohei Sotomi, Kazushige Kadota, Masaaki Uematsu, Masanobu Ohya, Yoshinobu Onuma, Kouichi Tachibana, Takeshi Kimura, Yoshisato Shibata, Ken Kozuma, J.J. Popma, & Koichi Nakao. (2017). Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial. EuroIntervention, 12(14), 1738–1746.
Chicago
Tetsuya Tobaru, Kengo Tanabe, Tomohiro Kawasaki, Gregg W. Stone, Patrick W. Serruys, Koichi Kishi, Yoshihiro Morino, et al. 2017. “Impact of Lesion Calcification on Angiographic Outcomes after Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold Implantation: An Observation from the ABSORB Japan Trial.” EuroIntervention 12 (14): 1738–46. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ab69e4a41d28bc58fba51d25e9549029&authtype=sso&custid=ns315887.